Lonza Group Ltd

LONN: XSWX (CHE)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
>yCLOCK|kL$%NLOCK|yjRGt%

Lonza Earnings: Strong Demand for Outsourced Drug Manufacturing Supports Long-Term Growth

Lonza delivered 19% constant-currency sales growth and core EBITDA margin of nearly 30% in the first half of 2025.

Sponsor Center